These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 7958337)
21. [Oxidative phosphorylation in relation to the fatty acid oxidation of liver mitochondria]. EMMELOT P Arch Int Physiol Biochim; 1954 Dec; 62(4):560-1. PubMed ID: 13218830 [No Abstract] [Full Text] [Related]
22. FAM13A, A Fatty Acid Oxidation Switch in Mitochondria. Friend or Foe in Chronic Obstructive Pulmonary Disease Pathogenesis? Hawkins GA; Mora AL Am J Respir Cell Mol Biol; 2017 Jun; 56(6):689-691. PubMed ID: 28569593 [No Abstract] [Full Text] [Related]
26. Fatty acid oxidation in malignant and normal livers. IV. The mechanism of the stimulatory effect of some alpha-oxy-acids on fatty acid oxidation in cellfree tissue preparations of normal livers. EMMELOT P; BOS CJ Enzymologia; 1954 Jul; 17(1):13-22. PubMed ID: 14353050 [No Abstract] [Full Text] [Related]
27. Deficiency of the pyruvate dehydrogenase complex and of mitochondrial fatty acid oxidation. Bindoff LA; Birch-Machin MA; Jackson S; Singh Kler R; Bartlett K; Turnbull DM Rev Neurol (Paris); 1991; 147(6-7):526-31. PubMed ID: 1962058 [TBL] [Abstract][Full Text] [Related]
30. Fluxing the mitochondria to insulin resistance. Watt MJ; Hevener AL Cell Metab; 2008 Jan; 7(1):5-6. PubMed ID: 18177719 [TBL] [Abstract][Full Text] [Related]
31. Peroxisomal fatty acid alpha- and beta-oxidation in health and disease: new insights. Wanders RJ; van Roermund CW; Visser WF; Ferdinandusse S; Jansen GA; van den Brink DM; Gloerich J; Waterham HR Adv Exp Med Biol; 2003; 544():293-302. PubMed ID: 14713243 [No Abstract] [Full Text] [Related]
32. The activation of fatty acid oxidation by kidney and liver mitochondria. JUDAH JD; REES KR Biochem J; 1953 Nov; 55(4):664-8. PubMed ID: 13115352 [No Abstract] [Full Text] [Related]
33. Mitochondrial and peroxisomal fatty acid oxidation in elasmobranchs. Moyes CD; Buck LT; Hochachka PW Am J Physiol; 1990 Mar; 258(3 Pt 2):R756-62. PubMed ID: 2316720 [TBL] [Abstract][Full Text] [Related]
34. Fatty acid oxidation in malignant and normal livers. III. The stimulatory effect of alpha-oxycaproate on fatty acid oxidation of normal livers studied with C14. BARENDREGT TJ; EMMELOT P; BOS CJ Enzymologia; 1954 Jul; 17(1):9-12. PubMed ID: 14353049 [No Abstract] [Full Text] [Related]
35. Regulation of mitochondrial fatty acid β-oxidation in human: what can we learn from inborn fatty acid β-oxidation deficiencies? Bastin J Biochimie; 2014 Jan; 96():113-20. PubMed ID: 23764392 [TBL] [Abstract][Full Text] [Related]
36. Formation and degradation of dicarboxylic acids in relation to alterations in fatty acid oxidation in rats. Mortensen PB Biochim Biophys Acta; 1992 Feb; 1124(1):71-9. PubMed ID: 1543729 [TBL] [Abstract][Full Text] [Related]
38. Peroxisomal fatty acid beta-oxidation in relation to adrenoleukodystrophy. Wanders RJ; Tager JM Dev Neurosci; 1991; 13(4-5):262-6. PubMed ID: 1817031 [TBL] [Abstract][Full Text] [Related]
39. Factors influencing the fatty acid oxidation of tumor mitochondria with special reference to changes in spontaneous mouse hepatomas. EMMELOT P; BOS CJ Experientia; 1955 Sep; 11(9):353-4. PubMed ID: 13262024 [No Abstract] [Full Text] [Related]